Intrinsic Value of S&P & Nasdaq Contact Us

Alvotech ALVO NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
59/100
3/7 Pass
SharesGrow Intrinsic Value
$76.24
+2059.8%
Analyst Price Target
$8.60
+143.6%

Stock Statistics — ALVO

Alvotech (ALVO) has a market capitalization of $1.1B and trades at $3.53. The 52-week range is 3.03-11.85.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 35.3, Earnings Per Share (EPS) of $0.10, annual revenue of $586.32M.

The stock has a beta of 0.25, operates in the Healthcare sector.

Trading Data
Current Price$3.53
52-Week Range3.03-11.85
Volume268.59K
Avg Volume (30D)535.48K
Market Cap$1.1B
Beta (1Y)0.25
Company
IPO Date2022-06-16
Employees1,012
CEOVilhelm Robert Wessman
CountryIS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINLU2458332611
CUSIPL01800108
Income (Latest Year)
Revenue$586.32M
Gross Profit$350.76M
EBITDA$323.39M
Operating Income$78.21M
Net Income$27.92M
EPS$0.10
EPS Diluted$0.10
Shares Outstanding$279.19M
Balance Sheet (Latest Year)
Total Assets$1.49B
Current Assets$574.02M
Cash & ST Investments$172.36M
Total Liabilities$1.77B
Total Debt$1.45B
Net Debt$1.28B
Total Equity$-284.49M
Debt / Equity-5.09
Valuation Ratios
P/E Ratio35.3
P/S Ratio1.88
EV/EBITDA (approx)3.4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message